AR093530A1 - Adyuvante de vacunacion, preparacion, y vacunas que lo contienen - Google Patents

Adyuvante de vacunacion, preparacion, y vacunas que lo contienen

Info

Publication number
AR093530A1
AR093530A1 ARP130104247A ARP130104247A AR093530A1 AR 093530 A1 AR093530 A1 AR 093530A1 AR P130104247 A ARP130104247 A AR P130104247A AR P130104247 A ARP130104247 A AR P130104247A AR 093530 A1 AR093530 A1 AR 093530A1
Authority
AR
Argentina
Prior art keywords
preparation
antigens
vaccination
assistant
vaccines containing
Prior art date
Application number
ARP130104247A
Other languages
English (en)
Inventor
Amaury Ferreira Chiesa Fernando
Ines Bessio Prato Maria
Quirici Valadan Leonora
Fernando Silveira Gonzalez Luis
Original Assignee
Amaury Ferreira Chiesa Fernando
Ines Bessio Prato Maria
Quirici Valadan Leonora
Fernando Silveira Gonzalez Luis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amaury Ferreira Chiesa Fernando, Ines Bessio Prato Maria, Quirici Valadan Leonora, Fernando Silveira Gonzalez Luis filed Critical Amaury Ferreira Chiesa Fernando
Publication of AR093530A1 publication Critical patent/AR093530A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Composición, preparación y empleo como adyuvante para uso animal o humano, de una formulación que comprende por lo menos un ácido biliar o sus sales y saponina, para potenciar la respuesta inmune contra un antígeno, que puede estar bien definido o no, incluyendo pero sin limitarse a bacterinas, antígenos y preparados antigénicos virales, bacterianos, parasitarios, y antígenos asociados con enfermedades tales como distintos tipos de cáncer. Los antígenos empleados pueden ser aislados de patógenos, así como productos de su modificación química o enzimática, antígenos recombinantes o sintéticos, o mezclas de los anteriores.
ARP130104247A 2012-12-10 2013-11-18 Adyuvante de vacunacion, preparacion, y vacunas que lo contienen AR093530A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY0001034506A UY34506A (es) 2012-12-10 2012-12-10 Adyuvante de vacunación, preparación y vacunas que lo contienen

Publications (1)

Publication Number Publication Date
AR093530A1 true AR093530A1 (es) 2015-06-10

Family

ID=50934708

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130104247A AR093530A1 (es) 2012-12-10 2013-11-18 Adyuvante de vacunacion, preparacion, y vacunas que lo contienen

Country Status (8)

Country Link
US (1) US20150313991A1 (es)
EP (1) EP2929894B1 (es)
AR (1) AR093530A1 (es)
AU (1) AU2013360504B2 (es)
BR (1) BR112015013625A2 (es)
CL (1) CL2015001618A1 (es)
UY (1) UY34506A (es)
WO (1) WO2014092528A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108272824A (zh) * 2018-03-11 2018-07-13 张显英 一种胆汁提取工艺
JP7258156B2 (ja) * 2018-09-25 2023-04-14 イーチャン・ヒューマンウェル・ファーマシューティカル・カンパニー・リミテッド 免疫調節薬としてのｔｇｒ５シグナル伝達のレギュレーター
EP3669890A1 (en) * 2018-12-18 2020-06-24 Croda International PLC Filamentous nanoparticles having vaccine adjuvant effect
RU2741834C1 (ru) * 2020-07-17 2021-01-29 Муса Тажудинович Абидов Вакцина и способ повышения иммуногенности и специфической активности средств профилактики инфекций

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1331443C (en) * 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
CA2096650A1 (en) * 1991-09-18 1993-03-21 Keith E. Langley Hepatitis b vaccine formulation incorporating a bile acid salt
WO1995009179A1 (en) * 1993-09-30 1995-04-06 Seed Capital Investments (Sci) B.V. Compounds with adjuvant activity
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
AUPO517897A0 (en) * 1997-02-19 1997-04-11 Csl Limited Chelating immunostimulating complexes
GB9817052D0 (en) 1998-08-05 1998-09-30 Smithkline Beecham Biolog Vaccine
CA2383105C (en) * 1999-09-24 2010-01-26 Smithkline Beecham Biologicals S.A. Intranasal influenza virus vaccine
PT1361890E (pt) * 2001-02-23 2011-06-07 Glaxosmithkline Biolog Sa Formulações vacinais de influenza para distribuição intradérmica
KR20090051129A (ko) 2004-04-05 2009-05-20 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
US8343498B2 (en) * 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics

Also Published As

Publication number Publication date
US20150313991A1 (en) 2015-11-05
AU2013360504A1 (en) 2015-07-02
EP2929894B1 (en) 2018-02-21
WO2014092528A1 (es) 2014-06-19
CL2015001618A1 (es) 2016-05-27
UY34506A (es) 2014-06-30
AU2013360504B2 (en) 2016-12-01
EP2929894A4 (en) 2015-12-02
EP2929894A1 (en) 2015-10-14
BR112015013625A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
CY1121789T1 (el) Νεες ανοσοενισχυτικες συνθεσεις
MX2019005268A (es) Vacuna peptidica para prevencion e inmunoterapia de la demencia tipo alzheimer.
CR20170419A (es) Nuevos péptidos y nueva combinación de péptidos para el uso en la inmunoterapia contra el cáncer de páncreas y otros tipos de cáncer.
CR20180027A (es) Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la misma terapia contra el cáncer epitelial de ovario y otros tipos de cáncer.
BR112017008165A2 (pt) anticorpos de domínio único direcionados contra antígenos intracelulares
BR112018017307A2 (pt) molécula de ácido nucleico isolada, composição, e, métodos para indução de uma resposta imune contra um zika vírus, para tratamento de um indivíduo e para prevenção de uma infecção por zika vírus
AR089797A1 (es) Vacunas contra clostridum difficile que comprenden toxinas recombinantes
BR112013022397A2 (pt) vacinas combinadas com doses menores de antígeno e/ou adjuvante
CY1120430T1 (el) Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
CR10559A (es) Vacuna de influenza
UY33297A (es) Composiciones farmaceuticas que comprenden un polipéptido que comprende al menos un motivo cxxc y antígenos heterólogos y usos de las mismas
BR112016015422A2 (pt) formulações de vacina de frasco único
AR080111A1 (es) Metodos y composiciones de inmunizacion
MX2015007753A (es) Composicion de vacunas para sujetos intactos.
EA201590829A1 (ru) Новые мукозные адъюванты и системы доставки
BR112014023414A2 (pt) vacina de herpesvirus-1 equino recombinante contendo uma glicoproteína c mutante e seus usos
WO2017142843A8 (en) Novel antigen for use in malaria vaccine
WO2014205199A3 (en) Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
CL2015002513A1 (es) Vacuna acelular contra pertussis
AR093530A1 (es) Adyuvante de vacunacion, preparacion, y vacunas que lo contienen
MX349657B (es) Composiciones de vacuna de matriz de proteína que incluyen policationes.
BR112015022582A2 (pt) molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo
BR112014020025A2 (pt) vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas
BR112013013016A2 (pt) modulação de imunogenicidade de antígeno pela eliminação de epítopos reconhecidos pelas células nkt14
BR112014003278A2 (pt) vacinas para influenza h5

Legal Events

Date Code Title Description
FB Suspension of granting procedure